Misoprostol Versus Dilapan-S for Cervical Preparation
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the dilatory effect of 400 mcg of buccally
administered misoprostol to one Dilapan-S rod placed 3-4 hours before abortion by dilation
and evacuation in women who are 12 weeks 0 days to 15 weeks 0 days gestation.
Phase:
N/A
Details
Lead Sponsor:
Planned Parenthood League of Massachusetts
Collaborator:
Society of Family Planning
Treatments:
Hydroxocobalamin Misoprostol Vitamin B 12 Vitamin B Complex Vitamins